This study explores the hypothesis that the use of an adjuvanted influenza vaccine in the elderly will produce greater vaccine effectiveness in their group.
To evaluate the effectiveness of adjuvanted trivalent inactivated influenza vaccine in the elderly (aged ≥ 65 years) through the reduction in relative risk of microbiologically confirmed influenza illness
Study Type
OBSERVATIONAL
Enrollment
1,000
Fraser Health Authority
Surrey, British Columbia, Canada
RECRUITINGVaccine effectiveness against laboratory confirmed influenza illness
Evaluation of the effectiveness of an adjuvanted TIV in the elderly aged ≥65 years, through the reduction in relative risk of microbiologically confirmed influenza illness
Time frame: Influenza season 2011/12 and 2012/13
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.